ODAIA in its US$13.8 million Series A financing round




US$13.8 million


Emerging and High Growth Companies

Date Closed

February 2022



Lead Office



On February 10, 2022, ODAIA announced it had completed its US$13.8 million Series A financing round led by Boston-based Flint Capital, with participation from Boston’s Innospark Ventures, New Hampshire-based Alumni Ventures, and Graphite Ventures. The round also included support from existing Canadian investors BDC Capital’s Women in Technology Fund, MaRS IAF, StandUp Ventures, Panache Ventures, and more. With this funding, ODAIA plans on increasing its number of employees and intends to focus its hiring efforts on its commercial team in the United States, where it has recently opened a new office in Boston.

ODAIA is a Toronto-based software start-up that works with pharma customers across a variety of different disease areas providing its software via a SaaS-based model per therapeutic area.

Osler, Hoskin & Harcourt LLP advised ODAIA with a team consisting of Chad Bayne, Gary Marshall, Chres Lee, Handi Xu and Dhananjay Ghildyal (Emerging and High Growth Companies)